IRCT201506201556N77已完成2 期
Duloxetine as adjunctive treatment of negative symptoms in patients with schizophrenia: a double blind and placebo controlled trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •1-Diagnosis of Schizophrenia based on DSM-5 criteria; 2- Age between 18-60; 3-Chronic Schizophrenia- duration of the disorder more than 2 years; 4-Minimum score of 20 in negative sub score. 5-being stable on risperidone for the last 2 months Exclusion criteria:1-Any serious medical or neurological problem; 2- IQ less than 70; 3- Substance dependence during the last 6 months(except for nicotine and caffeine); 4- Score on HDRS less than 14 5-receiving ECT during the last 3 months ; 6-Acute or chronic systemic diseases; 7- History of neurosurgery; 8- History of head trauma
排除标准
- 未提供
研究者
相似试验
已完成
不适用
The effect of Deluxitine on the negative symptoms of schizophreniaIRCT20191218045795N2Sanandaj University of Medical Sciences44
招募中
2 期
Vortioxetine as adjunctive treatment of schizophreniaSchizophrenia.SchizophreniaIRCT201710241556N100Tehran University of Medical Sciences50
已完成
不适用
Doluxetine add on conventional treatment in in?ammatory bowel disease patientsCondition 1: In?ammatory bowel disease. Condition 2: In?ammatory bowel disease.Crohn disease [regional enteritis]Ulcerative colitisIRCT201411127841N8Isfahan University of Medical Sciences, Psychosomatic Research Center40
已完成
不适用
Duloxetine plus collaborative care treatment versus Duloxetine alone in the treatment of concomitant pain and depressive disorder. A randomized clinical trial in primary care.DepressionpijnklachtenMajor Depressive Dissorder10027946NL-OMON31476Trimbos instituut116
已完成
不适用
Efficacy and complication of Duloxetine in attention deficeit –hyperactivity disorder (ADHD) and comparison with RitaliIRCT201110127462N2Tehran University of Medical Sciences40